Cargando…

Multiple rare and common variants in APOB gene locus associated with oxidatively modified low-density lipoprotein levels

Oxidatively modified low-density lipoproteins (oxLDL) play an important role in the occurrence and progression of atherosclerosis. To identify the genetic factors influencing the oxLDL levels, we have genotyped 776 DNA samples of Russian individuals for 196,725 single-nucleotide polymorphisms (SNPs)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Khlebus, Eleonora, Kutsenko, Vladimir, Meshkov, Alexey, Ershova, Alexandra, Kiseleva, Anna, Shevtsov, Anton, Shcherbakova, Natalia, Zharikova, Anastasiia, Lankin, Vadim, Tikhaze, Alla, Chazova, Irina, Yarovaya, Elena, Drapkina, Oksana, Boytsov, Sergey
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6544350/ https://www.ncbi.nlm.nih.gov/pubmed/31150472 http://dx.doi.org/10.1371/journal.pone.0217620

Ejemplares similares

Associations of SNPs of the ADIPOQ Gene with Serum Adiponectin Levels, Unstable Angina, and Coronary Artery Disease
por: Smetnev, Stepan, et al.
Publicado: (2019)

The LDLR, APOB, and PCSK9 Variants of Index Patients with Familial Hypercholesterolemia in Russia
por: Meshkov, Alexey, et al.
Publicado: (2021)

Lipoprotein Profile in Populations from Regions of the Russian Federation: ESSE-RF Study
por: Metelskaya, Victoria A., et al.
Publicado: (2022)

Cystic Fibrosis Polymorphic Variants in a Russian Population
por: Kiseleva, Anna, et al.
Publicado: (2020)

Lipoprotein(a) in an adult sample from the Russian population: distribution and association with atherosclerotic cardiovascular diseases
por: Ezhov, Marat V., et al.
Publicado: (2021)

Dicarbonyl-Dependent Modification of LDL as a Key Factor of Endothelial Dysfunction and Atherosclerotic Vascular Wall Damage
por: Lankin, Vadim Z., et al.
Publicado: (2022)

Malondialdehyde as an Important Key Factor of Molecular Mechanisms of Vascular Wall Damage under Heart Diseases Development
por: Lankin, Vadim Z., et al.
Publicado: (2022)

The Prevalence of Heterozygous Familial Hypercholesterolemia in Selected Regions of the Russian Federation: The FH-ESSE-RF Study
por: Meshkov, Alexey N., et al.
Publicado: (2021)

Case Report: Hypertriglyceridemia and Premature Atherosclerosis in a Patient With Apolipoprotein E Gene ε2ε1 Genotype
por: Limonova, Alena S., et al.
Publicado: (2021)

Applicability of Diagnostic Criteria and High Prevalence of Familial Dysbetalipoproteinemia in Russia: A Pilot Study
por: Blokhina, Anastasia V., et al.
Publicado: (2023)

A Data-Driven Approach to Carrier Screening for Common Recessive Diseases
por: Kiseleva, Anna V., et al.
Publicado: (2020)

Phenotypic vs. genetic cascade screening for familial hypercholesterolemia: A case report
por: Blokhina, Anastasia V., et al.
Publicado: (2022)

Clearance and Utilization of Dicarbonyl-Modified LDL in Monkeys and Humans
por: Lankin, Vadim Z., et al.
Publicado: (2023)

Identification of Pathogenic Variant Burden and Selection of Optimal Diagnostic Method Is a Way to Improve Carrier Screening for Autosomal Recessive Diseases
por: Sotnikova, Evgeniia A., et al.
Publicado: (2022)

SAA is Found on ApoB-Containing Lipoproteins in Obese Diabetic Humans
por: Jahangiri, Anisa, et al.
Publicado: (2013)

Case Report: Next Generation Sequencing in Clinical Practice–A Real Tool for Ending the Protracted Diagnostic Odyssey
por: Limonova, Alena S., et al.
Publicado: (2022)

Major and minor ECG abnormalities depending on regional living conditions in Russia
por: Maksimov, Sergey, et al.
Publicado: (2023)

The Double Mutation DSG2-p.S363X and TBX20-p.D278X Is Associated with Left Ventricular Non-Compaction Cardiomyopathy: Case Report
por: Myasnikov, Roman, et al.
Publicado: (2021)

ApoB48-Lipoproteins Are Associated with Cardiometabolic Risk in Adolescents with and without Polycystic Ovary Syndrome
por: Vine, Donna F, et al.
Publicado: (2020)

Biosynthesis of lipoprotein: location of nascent apoAI and apoB in the rough endoplasmic reticulum of chicken hepatocytes
Publicado: (1992)

Proteoglycan binding as proatherogenic function metric of apoB-containing lipoproteins and chronic kidney graft failure
por: Steffen, Hannah L.M., et al.
Publicado: (2021)

Mouse, but Not Human, ApoB-100 Lipoprotein Cholesterol Is a Potent Innate Inhibitor of Streptococcus pneumoniae Pneumolysin
por: Wade, Kristin R., et al.
Publicado: (2014)

The elevation of plasma concentrations of apoB-48-containing lipoproteins in familial hypercholesterolemia is independent of PCSK9 levels
por: Drouin-Chartier, Jean-Philippe, et al.
Publicado: (2017)

Uncoupling associations of risk alleles with endophenotypes and phenotypes: insights from the ApoB locus and heart‐related traits
por: Kulminski, Alexander M., et al.
Publicado: (2016)

Investigation of human apoB48 metabolism using a new, integrated non‐steady‐state model of apoB48 and apoB100 kinetics
por: Björnson, E., et al.
Publicado: (2019)

Antisense oligonucleotide-induced alternative splicing of the APOB mRNA generates a novel isoform of APOB
por: Khoo, Bernard, et al.
Publicado: (2007)

ApoA-I/A-II-HDL positively associates with apoB-lipoproteins as a potential atherogenic indicator
por: Kido, Toshimi, et al.
Publicado: (2017)

Rare and common variants of APOB and PCSK9 in Korean patients with extremely low low-density lipoprotein-cholesterol levels
por: Lee, Chan Joo, et al.
Publicado: (2017)

Rare Protein-Truncating Variants in APOB, Lower Low-Density Lipoprotein Cholesterol, and Protection Against Coronary Heart Disease
por: Peloso, Gina M., et al.
Publicado: (2019)

Hemi- and Homozygous Loss-of-Function Mutations in DSG2 (Desmoglein-2) Cause Recessive Arrhythmogenic Cardiomyopathy with an Early Onset
por: Brodehl, Andreas, et al.
Publicado: (2021)

Associations of the APOB rs693 and rs17240441 polymorphisms with plasma APOB and lipid levels: a meta-analysis
por: Niu, Caiqin, et al.
Publicado: (2017)

A Case of Severe Left-Ventricular Noncompaction Associated with Splicing Altering Variant in the FHOD3 Gene
por: Myasnikov, Roman, et al.
Publicado: (2022)

Hepatic S1P deficiency lowers plasma cholesterol levels in apoB-containing lipoproteins when LDLR function is compromised
por: Basu, Debapriya, et al.
Publicado: (2015)

Targeted Sequencing of 242 Clinically Important Genes in the Russian Population From the Ivanovo Region
por: Ramensky, Vasily E., et al.
Publicado: (2021)

The Desmin (DES) Mutation p.A337P Is Associated with Left-Ventricular Non-Compaction Cardiomyopathy
por: Kulikova, Olga, et al.
Publicado: (2021)

Regulation of plasma LDL: the apoB paradigm
por: Sniderman, Allan D., et al.
Publicado: (2009)

The Enzymatic Activity of APOBE3G Multimers
por: Pan, Yangang, et al.
Publicado: (2018)

Clinical significance of APOB inactivation in hepatocellular carcinoma
por: Lee, Gena, et al.
Publicado: (2018)

Potential role of ATM in hepatocyte endocytosis of ApoE-deficient, ApoB48-containing lipoprotein in ApoE-deficient mice
por: WU, JIANHUA, et al.
Publicado: (2014)

Disruption of the ERLIN–TM6SF2–APOB complex destabilizes APOB and contributes to non-alcoholic fatty liver disease
por: Li, Bo-Tao, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6ukvu1gop8e2tto016cd3ibacq